PUBLIC CONTRACT · 2022

4180232/2022-aq. Central D559 - Darunavir 800 mg + cobic 150 mg+ emtricitabi 200 mg + tenofovir alaf 10 mg comp

Contract value
€89,007.24
Signed on
22 May 2022
Procedure
Ao abrigo de acordo-quadro (art.º 258.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9865014

PUBLISHED SUBJECT

4180232/2022-AQ. CENTRAL D559 - DARUNAVIR 800 MG + COBIC 150 MG+ EMTRICITABI 200 MG + TENOFOVIR ALAF 10 MG COMP

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Setúbal, Barreiro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412

HOW MUCH AND WHEN

Values and timeline

Contract price
€89,007.24
Procedure base price
€89,007.24
Total effective price
€89,007.24
Publication date
15 March 2023
Award date
20 May 2022
Signing date
22 May 2022
Performance period
2 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 258.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 258.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
6397624

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts